The role of microRNAs in modulation of the immune escape of tumors
4 Apr 2016
The role of microRNAs in modulation of the immune escape of tumors
Reprogramming the cancer microenvironment with vaccine-based therapy
Biomarkers in t-cell therapy trials
Immunotherapy and personalised medicine in review
Rationale for combining immunotherapy with chemotherapy
Editor's Choice for March 2016
Patient data: its role in iManageCancer and the p-medicine project
New strategies for ms-based metabolomics
Polycystic kidney disease: Identifying a pathogenic pathway
The occurrence of septic shock: difficulty in predicting the outcomes
Mass spectrometry: a key metabolomics platform in metabolic diseases
Pharmametabolomics and the integration of metabolomics in drug discovery